Cosciens Biopharma Inc (0UGB)
LSE
The current 0UGB market cap is 7.92M. The company's latest EPS is USD -3.4086 and P/E is -1.19.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 532k | 3.87M | 5.26M | 5.64M | 4.5M |
Operating Income | -10.04M | -5.96M | -5.33M | -20.99M | -18.01M |
Net Income | -6.04M | -5.12M | -8.37M | -22.73M | -16.55M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 19.98M | 37.28M | 80.1M | 56.03M | 37.02M |
Total Liabilities | 22.44M | 24.07M | 27.12M | 20.25M | 18.82M |
Total Equity | -2.46M | 13.21M | 52.99M | 35.78M | 18.2M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -10.73M | -4.13M | -8.58M | -13.68M | -17.12M |
Investing | 50k | 56k | -658k | -12k | 528k |
Financing | 3.89M | 20.47M | 51.04M | -118k | -151k |
Market Cap | 7.92M |
Price to Earnings Ratio | -1.19 |
Price to Sales Ratio | 4.37 |
Price to Cash Ratio | 0.58 |
Price to Book Ratio | 1.08 |
Dividend Yield | - |
Shares Outstanding | 4.86M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | 0.01% |
52 Week High | 1.6316 |
52 Week Low | 1.6313 |
Spread (Intraday) | 0 (0%) |
Company Name | Cosciens Biopharma Inc |
Address |
aeterna zentaris inc toronto, ontario M5K 1E7 |
Website | https://www.zentaris.com/ |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.